| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |